Advanced MRI metrics improve the prediction of baseline disease severity for individuals with degenerative cervical myelopathy.

DCM artificial intelligence degenerative cervical myelopathy machine learning magnetic resonance imaging spinal cord injury

Journal

The spine journal : official journal of the North American Spine Society
ISSN: 1878-1632
Titre abrégé: Spine J
Pays: United States
ID NLM: 101130732

Informations de publication

Date de publication:
26 Apr 2024
Historique:
received: 22 01 2024
revised: 05 04 2024
accepted: 23 04 2024
medline: 29 4 2024
pubmed: 29 4 2024
entrez: 28 4 2024
Statut: aheadofprint

Résumé

Degenerative cervical myelopathy (DCM) is the most common form of atraumatic spinal cord injury globally. Degeneration of spinal discs, bony osteophyte growth and ligament pathology results in physical compression of the spinal cord contributing to damage of white matter tracts and grey matter cellular populations. This results in an insidious neurological and functional decline in patients which can lead to paralysis. Magnetic resonance imaging (MRI) confirms the diagnosis of DCM and is a prerequisite to surgical intervention, the only known treatment for this disorder. Unfortunately, there is a weak correlation between features of current commonly acquired MRI scans ("community MRI, cMRI") and the degree of disability experienced by a patient. This study examines the predictive ability of current MRI sequences relative to "advanced MRI" (aMRI) metrics designed to detect evidence of spinal cord injury secondary to degenerative myelopathy. We hypothesize that the utilization of higher fidelity aMRI scans will increase the effectiveness of machine learning models predicting DCM severity and may ultimately lead to a more efficient protocol for identifying patients in need of surgical intervention. Single institution analysis of imaging registry of patients with DCM. 296 patients in the cMRI group and 228 patients in the aMRI group. Physiologic measures: Accuracy of machine learning algorithms to detect severity of DCM assessed clinically based on the modified Japanese Orthopedic Association (mJOA) scale. Patients enrolled in the Canadian Spine Outcomes Research Network registry with DCM were screened and 296 cervical spine MRIs acquired in cMRI were compared with 228 aMRI acquisitions. aMRI acquisitions consisted of diffusion tensor imaging, magnetization transfer, T Through the utilization of Random Forest Classifiers, disease severity was predicted with 41.8% accuracy in cMRI scans and 73.3% in the aMRI scans. Across different predictive model variations tested, the aMRI scans consistently produced higher prediction accuracies compared to the cMRI counterparts. aMRI metrics perform better in machine learning models at predicting disease severity of patients with DCM. Continued work is needed to refine these models and address DCM severity class imbalance concerns, ultimately improving model confidence for clinical implementation.

Sections du résumé

BACKGROUND CONTEXT BACKGROUND
Degenerative cervical myelopathy (DCM) is the most common form of atraumatic spinal cord injury globally. Degeneration of spinal discs, bony osteophyte growth and ligament pathology results in physical compression of the spinal cord contributing to damage of white matter tracts and grey matter cellular populations. This results in an insidious neurological and functional decline in patients which can lead to paralysis. Magnetic resonance imaging (MRI) confirms the diagnosis of DCM and is a prerequisite to surgical intervention, the only known treatment for this disorder. Unfortunately, there is a weak correlation between features of current commonly acquired MRI scans ("community MRI, cMRI") and the degree of disability experienced by a patient.
PURPOSE OBJECTIVE
This study examines the predictive ability of current MRI sequences relative to "advanced MRI" (aMRI) metrics designed to detect evidence of spinal cord injury secondary to degenerative myelopathy. We hypothesize that the utilization of higher fidelity aMRI scans will increase the effectiveness of machine learning models predicting DCM severity and may ultimately lead to a more efficient protocol for identifying patients in need of surgical intervention.
STUDY DESIGN/SETTING METHODS
Single institution analysis of imaging registry of patients with DCM.
PATIENT SAMPLE METHODS
296 patients in the cMRI group and 228 patients in the aMRI group.
OUTCOME MEASURES METHODS
Physiologic measures: Accuracy of machine learning algorithms to detect severity of DCM assessed clinically based on the modified Japanese Orthopedic Association (mJOA) scale.
METHODS METHODS
Patients enrolled in the Canadian Spine Outcomes Research Network registry with DCM were screened and 296 cervical spine MRIs acquired in cMRI were compared with 228 aMRI acquisitions. aMRI acquisitions consisted of diffusion tensor imaging, magnetization transfer, T
RESULTS RESULTS
Through the utilization of Random Forest Classifiers, disease severity was predicted with 41.8% accuracy in cMRI scans and 73.3% in the aMRI scans. Across different predictive model variations tested, the aMRI scans consistently produced higher prediction accuracies compared to the cMRI counterparts.
CONCLUSIONS CONCLUSIONS
aMRI metrics perform better in machine learning models at predicting disease severity of patients with DCM. Continued work is needed to refine these models and address DCM severity class imbalance concerns, ultimately improving model confidence for clinical implementation.

Identifiants

pubmed: 38679077
pii: S1529-9430(24)00193-1
doi: 10.1016/j.spinee.2024.04.028
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declarations of Competing Interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Abdul Al-Shawwa (A)

Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Kalum Ost (K)

Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

David Anderson (D)

Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Newton Cho (N)

Department of Neurosurgery, University of Toronto, Toronto, ON, Canada.

Nathan Evaniew (N)

Combined Orthopedic and Neurosurgery Spine Program, University of Calgary, Calgary, AB, Canada; Section of Orthopaedic Surgery, Department of Surgery, University of Calgary, Calgary, AB, Canada.

W Bradley Jacobs (WB)

Combined Orthopedic and Neurosurgery Spine Program, University of Calgary, Calgary, AB, Canada; Department of Clinical Neurosciences, Section of Neurosurgery, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Allan R Martin (AR)

Department of Neurological Surgery, University of California - Davis, Sacramento, CA.

Ranjeet Gaekwad (R)

Department of Clinical Neurosciences, Section of Neurosurgery, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Saswati Tripathy (S)

Combined Orthopedic and Neurosurgery Spine Program, University of Calgary, Calgary, AB, Canada.

Jacques Bouchard (J)

Combined Orthopedic and Neurosurgery Spine Program, University of Calgary, Calgary, AB, Canada; Section of Orthopaedic Surgery, Department of Surgery, University of Calgary, Calgary, AB, Canada.

Steven Casha (S)

Combined Orthopedic and Neurosurgery Spine Program, University of Calgary, Calgary, AB, Canada; Department of Clinical Neurosciences, Section of Neurosurgery, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Roger Cho (R)

Combined Orthopedic and Neurosurgery Spine Program, University of Calgary, Calgary, AB, Canada; Section of Orthopaedic Surgery, Department of Surgery, University of Calgary, Calgary, AB, Canada.

Stephen duPlessis (S)

Combined Orthopedic and Neurosurgery Spine Program, University of Calgary, Calgary, AB, Canada; Department of Clinical Neurosciences, Section of Neurosurgery, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Peter Lewkonia (P)

Combined Orthopedic and Neurosurgery Spine Program, University of Calgary, Calgary, AB, Canada; Section of Orthopaedic Surgery, Department of Surgery, University of Calgary, Calgary, AB, Canada.

Fred Nicholls (F)

Combined Orthopedic and Neurosurgery Spine Program, University of Calgary, Calgary, AB, Canada; Section of Orthopaedic Surgery, Department of Surgery, University of Calgary, Calgary, AB, Canada.

Paul T Salo (PT)

Combined Orthopedic and Neurosurgery Spine Program, University of Calgary, Calgary, AB, Canada; Section of Orthopaedic Surgery, Department of Surgery, University of Calgary, Calgary, AB, Canada.

Alex Soroceanu (A)

Combined Orthopedic and Neurosurgery Spine Program, University of Calgary, Calgary, AB, Canada; Section of Orthopaedic Surgery, Department of Surgery, University of Calgary, Calgary, AB, Canada.

Ganesh Swamy (G)

Combined Orthopedic and Neurosurgery Spine Program, University of Calgary, Calgary, AB, Canada; Section of Orthopaedic Surgery, Department of Surgery, University of Calgary, Calgary, AB, Canada.

Kenneth C Thomas (KC)

Combined Orthopedic and Neurosurgery Spine Program, University of Calgary, Calgary, AB, Canada; Section of Orthopaedic Surgery, Department of Surgery, University of Calgary, Calgary, AB, Canada.

Michael M H Yang (MMH)

Combined Orthopedic and Neurosurgery Spine Program, University of Calgary, Calgary, AB, Canada; Department of Clinical Neurosciences, Section of Neurosurgery, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Julien Cohen-Adad (J)

NeuroPoly Lab, Institute of Biomedical Engineering, Polytechnique Montreal, Montreal, QC, Canada; Functional Neuroimaging Unit, CRIUGM, Université de Montréal, Montreal, QC, Canada; Mila - Quebec AI Institute, Montrèal, QC, Canada.

David W Cadotte (DW)

Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada; Combined Orthopedic and Neurosurgery Spine Program, University of Calgary, Calgary, AB, Canada; Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada; Department of Clinical Neurosciences, Section of Neurosurgery, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada. Electronic address: david.cadotte@ucalgary.ca.

Classifications MeSH